Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN
Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN
Price:
37.94 USD
3.32%
Market Closed
Updated:
May 29, 2024
Biohaven Pharmaceutical Holding Company Ltd
PP&E Gross
|
Biohaven Pharmaceutical Holding Company Ltd
PP&E Gross Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive PP&E Gross Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | PP&E Gross | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN
|
PP&E Gross
$48.6m
|
CAGR 3-Years
86%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
PP&E Gross
$5B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
9%
|
CAGR 10-Years
8%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Biohaven Pharmaceutical Holding Company Ltd's PP&E Gross?
PP&E Gross
48.6m
USD
48.6m
USD
Based on the financial report for Dec 31, 2023, Biohaven Pharmaceutical Holding Company Ltd's PP&E Gross amounts to 48.6m USD.
What is Biohaven Pharmaceutical Holding Company Ltd's PP&E Gross growth rate?
PP&E Gross CAGR 3Y
86%
86%
Over the last year, the PP&E Gross growth was -7%. The average annual PP&E Gross growth rates for Biohaven Pharmaceutical Holding Company Ltd have been 86% over the past three years .
You don't have any saved screeners yet
